Spanish health food firm Puleva Biotech, a unit of food company Ebro Puleva, has posted a 34% rise in first-half net profit.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The company’s net profit rose to €932,000 (US$1.06m), while revenue rose 23% to €2.28m.
Puleva Biotech said it was to launch a new product on the market in the coming weeks. The firm said tests of its CV-17 food additive showed that in small regular doses it “significantly reduced numerous risk factors connected to heart disease,” and the product would go on sale soon, reported Reuters.
